191 related articles for article (PubMed ID: 216767)
1. Naturally occurring lymphocyte-mediated immunity to endogenous type-C virus in the mouse. Blocking of the lymphocyte reactivity with antisera to the virus.
Kende M; Hill R; Dinowitz M; Stephenson JR; Kelloff GJ
J Exp Med; 1979 Feb; 149(2):358-71. PubMed ID: 216767
[TBL] [Abstract][Full Text] [Related]
2. Naturally occurring humoral immunity to endogenous xenotropic and amphotropic type-C virus in the mouse.
Kende M; Veronese F; Hill DW; Dinowitz M; Kelloff GJ
Int J Cancer; 1981 Feb; 27(2):235-42. PubMed ID: 6270013
[TBL] [Abstract][Full Text] [Related]
3. Natural immunity in mice to the envelope glycoprotein of endogenous ecotropic type C viruses: neutralization of virus infectivity.
Ihle JN; Lazar B
J Virol; 1977 Mar; 21(3):974-80. PubMed ID: 191656
[TBL] [Abstract][Full Text] [Related]
4. Characterization of the blastogenic and cytotoxic responses of normal mice to ecotropic C-type viral gp71.
Lee JC; Ihle JN
J Immunol; 1977 Mar; 118(3):928-34. PubMed ID: 191530
[TBL] [Abstract][Full Text] [Related]
5. Autogenous immunity to endogenous RNA tumor virus: reactivity of natural immune sera to antigenic determinants of several biologically distinct murine leukemia viruses.
Lee JC; Ihle JN
J Natl Cancer Inst; 1975 Oct; 55(4):831-8. PubMed ID: 52718
[TBL] [Abstract][Full Text] [Related]
6. Inhibition of normal mouse lymphocyte mitogen responses by xenogeneic or allogeneic antibodies to the MuLV glycoprotein gp71.
Lee JC; Ihle JN
J Immunol; 1976 Sep; 117(3):1033-8. PubMed ID: 182879
[TBL] [Abstract][Full Text] [Related]
7. Natural immunity in mice to structural polypeptides of endogenous type C RNA viruses.
Stephenson JR; Peters RL; Hino S; Donahoe RM; Long LK; Aaronson SA; Kelloff GJ
J Virol; 1976 Sep; 19(3):890-8. PubMed ID: 184303
[TBL] [Abstract][Full Text] [Related]
8. An approach to C-type virus immunoprevention of spontaneously occurring tumors in laboratory mice.
Kelloff GJ; Peters RL; Donahoe RM; Ghazzouli I; Sass B; Nims RM; Huebner RJ
Cancer Res; 1976 Feb; 36(2 pt 2):622-30. PubMed ID: 175922
[TBL] [Abstract][Full Text] [Related]
9. Immunity to virus-free syngeneic tumor cell transplantation in the BALB/c mouse after immunization with homologous tumor cells infected with type C virus.
Al-Ghazzouli IK; Donahoe RM; Huang KY; Sass B; Peters RL; Kelloff GJ
J Immunol; 1976 Dec; 117(6):2239-48. PubMed ID: 186539
[TBL] [Abstract][Full Text] [Related]
10. Cell-mediated immunity to leukemia virus- and tumor-associated antigens in mice.
Herberman RB; Holden HT; Ting CC; Lavrin DL; Kirchner H
Cancer Res; 1976 Feb; 36(2 pt 2):615-21. PubMed ID: 56223
[TBL] [Abstract][Full Text] [Related]
11. Mouse alloantibodies capable of blocking cytotoxic T-cell function. I. Relationship between the antigen reactive with blocking antibodies and the Lyt-2 locus.
Shinohara N; Sachs DH
J Exp Med; 1979 Sep; 150(3):432-44. PubMed ID: 113478
[TBL] [Abstract][Full Text] [Related]
12. Autogenous immunity to endogenous RNA tumor virus: humoral immune response to virus envelope antigens.
Hanna MG; Ihle JN; Lee JC
Cancer Res; 1976 Feb; 36(2 pt 2):608-14. PubMed ID: 56222
[TBL] [Abstract][Full Text] [Related]
13. Association of mouse major histocompatibility and Rauscher murine leukaemia virus envelope glycoprotein antigens on leukaemia cells and their recognition by syngeneic virus-immune-cytotoxic T-lymphocytes.
Zarling DA; Keshet I; Watson A; Bach FH
Scand J Immunol; 1978; 8(6):497-508. PubMed ID: 83670
[TBL] [Abstract][Full Text] [Related]
14. Humans have antibodies capable of recognizing oncoviral glycoproteins: demonstration that these antibodies are formed in response to cellular modification of glycoproteins rather than as consequence of exposure to virus.
Barbacid M; Bolognesi D; Aaronson SA
Proc Natl Acad Sci U S A; 1980 Mar; 77(3):1617-21. PubMed ID: 6154936
[TBL] [Abstract][Full Text] [Related]
15. Antibody-dependent cellular cytotoxicity against murine leukemia viral antigens: studies with human lymphoblastoid cell lines and human peripheral lymphocytes as effector cells comparing rabbit, goat, and mouse antisera.
Peters CJ; Theofilopoulos AN
J Immunol; 1977 Sep; 119(3):1089-96. PubMed ID: 70469
[TBL] [Abstract][Full Text] [Related]
16. Natural and experimentally induced antibodies to defined mammalian type-C virus proteins in primates.
Charman HP; Kim N; White M; Marquardt H; Gilden RV; Kawakami T
J Natl Cancer Inst; 1975 Dec; 55(6):1419-24. PubMed ID: 173868
[TBL] [Abstract][Full Text] [Related]
17. Cell-mediated immunity to antigens associated with endogenous murine C-type leukemia viruses.
Hirsch ME; Kelly AP; Proffitt MR; Black PH
Science; 1975 Mar; 187(4180):959-61. PubMed ID: 167435
[TBL] [Abstract][Full Text] [Related]
18. Dependence of initiation of an innocent bystander cytotoxicity reaction on the association of viral antigens and tumor cell membranes in mice.
Lopez DM; Lopez PF; Parks WP; Paul RD
J Natl Cancer Inst; 1986 May; 76(5):923-31. PubMed ID: 2871214
[TBL] [Abstract][Full Text] [Related]
19. Syngeneic monoclonal antibodies to B16 melanoma viral antigens.
Rappaport I; Alterman AL; Braverman S; Stackpole CW
Cancer Res; 1987 Oct; 47(20):5391-6. PubMed ID: 3652042
[TBL] [Abstract][Full Text] [Related]
20. Immunoprevention of naturally occurring endogenous murine type-C RNA viruses.
Kende M; Stephenson JR; Kelloff GJ; Al-Ghazzouli IK; Dinowitz M
Nature; 1978 Jun; 273(5661):383-5. PubMed ID: 207991
[No Abstract] [Full Text] [Related]
[Next] [New Search]
